Cassotide 50 mg (Bicalutamide) Quantity:60 Tablet/s The net effect is a

The net effect is a measurable decline in circulating LDL cholesterol and a modest rise in HDL cholesterol

Managing Maintenance Patient Concerns

01% with other eye drops

Users consistently highlight that they prefer the smooth capsule texture over traditional hard tablets

many patients use Gabapentin long-term

Cassotide 50 mg (Bicalutamide) Quantity:60 Tablet/s The net effect is aProduct Overview Cassotide 50 mg is a prescription oral tablet manufactured by Cipla Limited, containing the active ingredient bicalutamide 50 mg. It is classified as an anticancer agent and is specifically indicated for the treatment of advanced prostate cancer in adult men. The product is supplied in a strip containing ten tablets, each tablet being filmcoated for optimal stability. Cassotide is formulated to provide a consistent systemic exposure